Doug Jennings, Pharm.D. (@prof_j_nyc) 's Twitter Profile
Doug Jennings, Pharm.D.

@prof_j_nyc

Professor & Dept Chair | Heart Transplant & MCS @Columbia | ACC HF/TXP Leadership Council | Editorial Board @jcardfail | @ISHLT Guideline Co-author

ID: 1156731406841733120

calendar_today01-08-2019 01:00:33

518 Tweet

1,1K Takipçi

267 Takip Edilen

William Baker (@wbaker0621) 's Twitter Profile Photo

Shout out to Doug Jennings, Pharm.D. for co-authoring this HFSA consensus statement. Looks incredible. ACCP Cardiology PRN HFSA Expert Consensus Statement on the Medical Management of Patients on Durable Mechanical Circulatory Support onlinejcf.com/article/S1071-…

Starzl Transplantation Institute (@institutestarzl) 's Twitter Profile Photo

A medical breakthrough for patients, FK-506 was a more effective and potent immunosuppressant than what had been used previously. Dr. Starzl and his team of researchers were instrumental in its development and in providing support for its widespread use.

A medical breakthrough for patients, FK-506 was a more effective and potent immunosuppressant than what had been used previously.  Dr. Starzl and his team of researchers were instrumental in its development and in providing support for its widespread use.
Pharmacotherapy (@pharmacojournal) 's Twitter Profile Photo

Addition of hydrocortisone to norepinephrine was associated with a lower 28-day mortality in patients with septic shock, compared to the addition of vasopressin. buff.ly/3O0ab7i ACCP CRIT PRN

Addition of hydrocortisone to norepinephrine was associated with a lower 28-day mortality in patients with septic shock, compared to the addition of vasopressin. buff.ly/3O0ab7i <a href="/accpcritprn/">ACCP CRIT PRN</a>